why choose us

First received: August 30, 2023

Clinical Trial: Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Graft Versus Host Disease

Study Type: INTERVENTIONAL


Official Title: Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Brief Summary: This randomized placebo-controlled double-blind phase II trial tests whether fecal microorganism (microbiota) transplantation prevents severe acute graft versus host disease in adults undergoing allogeneic hematopoietic cell transplantation (HCT).Fecal microbiota transplantation involves receiving processed fecal material orally after allogeneic HCT in order to establish a healthy gut microbiota.Gut microbiota undergoes major alterations during allogeneic HCT because of antibiotic exposures, nutritional changes,…

Read more